Èn dosis intravenøs penicillin som tillæg til peroral penicillin i behandlingen af akut tonsillitis, peritonsillær phlegmone og peritonsillær absces – et randomiseret, dobbeltblindet, placebo-kontrolleret studie

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-526903-31-00

Enrollment

154

Registered

2026-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsillitis

Brief summary

STAT-10 score on Day 2 (for AT and PP) and PTAAT-12 score on Day 2 (for PTA), Time to symptom resolution

Detailed description

VAS pain score on Day 2. Total analgesic consumption during Days 1–7. Cumulative PTAAT-12 score during Days 1–7. Complications within 14 days. TOI-14 score at 6 and 12 months. Proportion of patients undergoing tonsillectomy at 6 and 12 months. Number of episodes of AT, PP, or PTA at 6 and 12 months., Estimated MCID for STAT-10 and estimated MCID for PTAAT-12

Interventions

DRUGBENZYLPENICILLIN

DRUGNaCl 0

DRUG9 % B. Braun

DRUGInjektionslösung

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
STAT-10 score on Day 2 (for AT and PP) and PTAAT-12 score on Day 2 (for PTA), Time to symptom resolution	—

Secondary

Measure	Time frame
VAS pain score on Day 2. Total analgesic consumption during Days 1–7. Cumulative PTAAT-12 score during Days 1–7. Complications within 14 days. TOI-14 score at 6 and 12 months. Proportion of patients undergoing tonsillectomy at 6 and 12 months. Number of episodes of AT, PP, or PTA at 6 and 12 months., Estimated MCID for STAT-10 and estimated MCID for PTAAT-12	—

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 22, 2026